Document Detail


Heart Failure with Anemia: Novel Findings on the Roles of Renal Disease, Interleukins, and Specific Left Ventricular Remodeling Processes.
MedLine Citation:
PMID:  25027873     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: -Anemia is a highly prevalent and strong independent prognostic marker in heart failure (HF), yet this association is not completely understood. Whether anemia is simply a marker of disease severity and concomitant chronic kidney disease (CKD) or represents the activation of other detrimental pathways remains uncertain. We sought to determine which pathophysiological pathways are exacerbated in patients with HF, reduced ejection fraction (HF-REF) and anemia; in comparison to those without anemia.
METHODS AND RESULTS: -In a prospective study involving 151 patients, selected biomarkers were analyzed; each representing proposed contributive mechanisms in the pathophysiology of anemia in HF. We compared clinical, echocardiographic and circulating biomarkers profiles between patients with HF-REF and anemia (group 1); HF-REF without anemia (group 2); and CKD with preserved EF, without established HF (CKD control group 3). We demonstrate here that many processes other than those related to CKD are involved in the anemia-HF relationship. These are linked to the pathophysiological mechanisms pertaining to left ventricular systolic dysfunction and remodeling, systemic inflammation and volume overload. We found that levels of IL-6 and IL-10, specific markers of cardiac remodeling (PIIINP, MMP2, TIMP-1, left atrial volume), myocardial stretch (NT-proBNP) and myocyte death (TnT) are related to anemia in HF-REF.
CONCLUSIONS: -Anemia is strongly associated with markers of more advanced and active heart disease, and not only with the level of renal dysfunction in HF-REF. Increased myocardial remodeling, inflammation and volume overload are the hallmarks of patients with anemia and HF. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00834691.
Authors:
Eileen O'Meara; Jean L Rouleau; Michel White; Karine Roy; Lucie Blondeau; Anique Ducharme; Paul-Eduard Neagoe; Martin G Sirois; Joël Lavoie; Normand Racine; Mark Liszkowski; François Madore; Jean-Claude Tardif; Simon de Denus
Related Documents :
9039153 - Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in shr.
1533563 - Morphologic consequences of systematic training.
15248063 - The neural crest is contiguous with the cardiac conduction system in the mouse embryo: ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-7-15
Journal Detail:
Title:  Circulation. Heart failure     Volume:  -     ISSN:  1941-3297     ISO Abbreviation:  Circ Heart Fail     Publication Date:  2014 Jul 
Date Detail:
Created Date:  2014-7-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Atrial Natriuretic Peptide Locally Counteracts the Deleterious Effects of Cardiomyocyte Mineralcorti...
Next Document:  Bridge-to-Decision Therapy with a Continuous-Flow External Ventricular Assist Device in Refractory C...